You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ)子公司擬收購天聖製藥部分醫藥商業公司股權
格隆匯 02-13 17:49

格隆匯2月13日丨重藥控股(000950.SZ)公佈,公司控股子公司重慶醫藥(集團)股份有限公司(“重慶醫藥”)與天聖製藥集團股份有限公司(“天聖製藥”)於2020年2月12日簽署了《股權轉讓意向協議》,重慶醫藥擬收購天聖製藥直接或間接持有的部分醫藥商業公司股權。

該協議僅為雙方對股權交易事項的初步意向,並非最終交易方案,具體交易方案仍需要進一步論證和溝通協商。同時,本次交易需按照相關法律、法規及《公司章程》的規定履行必要的審計、評估及相應審批程序。

天聖製藥下屬醫藥商業板塊主營與公司相近,其主要經營區域為重慶市區縣市場,公司通過此次股權收購,可以提升公司在重慶市區縣市場的份額。同時,通過公司的品種資源,物流網絡,企業文化輸出,增強新收購企業的盈利能力,從而進一步夯實公司的重慶大本營優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account